esomeprazolePapers
Papers about esomeprazole
- papers
- 199
Newest first
51 to 100 of 199Every paper here, unless its row says otherwiseIndexed under esomeprazole in PubMed's chemical list
Randomised clinical trial: gastrointestinal events in arthritis patients treated with celecoxib, ibuprofen or naproxen in the PRECISION trial.
Alimentary pharmacology & therapeutics2018PMID 29667211
Bismuth improves efficacy of proton-pump inhibitor clarithromycin, metronidazole triple Helicobacter pylori therapy despite a high prevalence of antimicrobial resistance.
Helicobacter2018PMID 29696736
Safety, tolerability, pharmacodynamics and pharmacokinetics of DWP14012, a novel potassium-competitive acid blocker, in healthy male subjects.
Alimentary pharmacology & therapeutics2018PMID 29863280Also compares against esomeprazole
A 6-month, multicenter, open-label study of fixed dose naproxen/esomeprazole in adolescent patients with juvenile idiopathic arthritis.
Pediatric rheumatology online journal2018PMID 29941047
Proton pump inhibitor as an independent factor of progression of abdominal aortic calcification in patients on maintenance hemodialysis.
PloS one2018PMID 29969455
Efficacy and safety of a fixed-dose combination of nimesulide/pantoprazole compared to naproxen/esomeprazole for pain relief in patients with osteoarticular diseases and dyspeptic symptoms.
Drug design, development and therapy2018PMID 30233140
Efficacy of naproxen with or without esomeprazole for pain and inflammation in patients after bilateral third molar extractions: A double blinded crossover study.
Medicina oral, patologia oral y cirugia bucal2017PMID 27918744
Efficacy of 1st-line bismuth-containing quadruple therapies with levofloxacin or clarithromycin for the eradication of Helicobacter pylori infection: A 1-week, open-label, randomized trial.
Medicine2017PMID 28207505
Randomized Clinical Trial: Esomeprazole, Bismuth, Levofloxacin, and Amoxicillin or Cefuroxime as First-Line Eradication Regimens for Helicobacter pylori Infection.
Digestive diseases and sciences2017PMID 28391418
Berberine containing quadruple therapy for initial Helicobacter pylori eradication: An open-label randomized phase IV trial.
Medicine2017PMID 28796053
Fourteen-day high-dose esomeprazole, amoxicillin and metronidazole as third-line treatment for Helicobacter pylori infection.
International journal of clinical practice2017PMID 28869699
Modified Helicobacter test using a new test meal and a 13C-urea breath test in Helicobacter pylori positive and negative dyspepsia patients on proton pump inhibitors.
World journal of gastroenterology2017PMID 28932087
Comparative Study of Clarithromycin- versus Metronidazole-Based Triple Therapy as First-Line Eradication for Helicobacter pylori.
Oncology2017PMID 29258111
Esomeprazole and rabeprazole did not reduce antiplatelet effects of aspirin/clopidogrel dual therapy in patients undergoing percutaneous coronary intervention: a prospective, randomized, case-control study.
Expert opinion on pharmacotherapy2016PMID 26549402
Changes in CYP2C19 enzyme activity evaluated by the [(13)C]-pantoprazole breath test after co-administration of clopidogrel and proton pump inhibitors following percutaneous coronary intervention and correlation to platelet reactivity.
Journal of breath research2016PMID 26815196
Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy.
Digestive and liver disease2016PMID 26847964
Esomeprazole, minocycline, metronidazole and bismuth as first-line and second-line regimens for Helicobacter pylori eradication.
Journal of digestive diseases2016PMID 26946480
Randomized clinical trial comparing ten day concomitant and sequential therapies for Helicobacter pylori eradication in a high clarithromycin resistance area.
European journal of internal medicine2016PMID 27134145
Efficacy of triple therapy with esomeprazole, amoxicillin, and sitafloxacin as a third-line Helicobacter pylori eradication regimen.
International journal of infectious diseases2016PMID 27590563
Comparison of the effects of esomeprazole 40 mg, rabeprazole 20 mg, lansoprazole 30 mg, and pantoprazole 40 mg on intragastrıc pH in extensive metabolizer patients with gastroesophageal reflux disease.
The Turkish journal of gastroenterology2016PMID 27782887
The effect of proton pump inhibitors on the CYP2C19 enzyme activity evaluated by the pantoprazole-13C breath test in GERD patients: clinical relevance for personalized medicine.
Journal of breath research2016PMID 27991432
Pharmacokinetic comparison study of a combination containing 500 mg of Naproxen and 20 mg of Esomeprazole: a randomized, single-dose, 2-way crossover, open-label study in healthy Korean men.
Clinical therapeutics2015PMID 25482305
Early effects of oral administration of esomeprazole and omeprazole on the intragastric pH.
Hepato-gastroenterology2015PMID 25916088
Risk of angle-closure glaucoma with bupropion and topiramate.
JAMA ophthalmology2015PMID 26158444
Comparison of the pharmacokinetics and tolerability of HCP1004 (a fixed-dose combination of naproxen and esomeprazole strontium) and VIMOVO® (a marketed fixed-dose combination of naproxen and esomeprazole magnesium) in healthy volunteers.
Drug design, development and therapy2015PMID 26257511Also measures esomeprazole
Onset and durability of pain relief in knee osteoarthritis: Pooled results from two placebo trials of naproxen/esomeprazole combination and celecoxib.
The Physician and sportsmedicine2015PMID 26313454
Comparative effectiveness and tolerability of esomeprazole and omeprazole in gastro-esophageal reflux disease: A systematic review and meta-analysis.
International journal of clinical pharmacology and therapeutics2015PMID 26329348
Randomised clinical trial: daily pantoprazole magnesium 40 mg vs. esomeprazole 40 mg for gastro-oesophageal reflux disease, assessed by endoscopy and symptoms.
Alimentary pharmacology & therapeutics2014PMID 24299323Also compares against esomeprazole
Multinational, double-blind, randomised, placebo-controlled, prospective study of esomeprazole in the prevention of recurrent peptic ulcer in low-dose acetylsalicylic acid users: the LAVENDER study.
Gut2014PMID 24326741
Impact of concomitant low-dose aspirin on the safety and tolerability of naproxen and esomeprazole magnesium delayed-release tablets in patients requiring chronic nonsteroidal anti-inflammatory drug therapy: an analysis from 5 Phase III studies.
Journal of thrombosis and thrombolysis2014PMID 24368727
A comparative study of sequential therapy and standard triple therapy for Helicobacter pylori infection: a randomized multicenter trial.
The American journal of gastroenterology2014PMID 24642580
Effect of esomeprazole with/without acetylsalicylic acid, omeprazole and lansoprazole on pharmacokinetics and pharmacodynamics of clopidogrel in healthy volunteers.
American journal of cardiovascular drugs2014PMID 24677117
Treatment of gastroesophageal reflux disease: two new oral formulations dexlansoprazole MR and esomezol (esomeprazole strontium).
Expert opinion on pharmacotherapy2014PMID 24749891Also returned by a PubMed search for esomeprazole
Comparative study of esomeprazole and lansoprazole in triple therapy for eradication of Helicobacter pylori in Japan.
World journal of gastroenterology2014PMID 24764674
The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis.
PloS one2014PMID 25394217
Esomeprazole for prevention and resolution of upper gastrointestinal symptoms in patients treated with low-dose acetylsalicylic acid for cardiovascular protection: the OBERON trial.
Journal of cardiovascular pharmacology2013PMID 23188121
Clinical evaluation of a ten-day regimen with esomeprazole, metronidazole, amoxicillin, and clarithromycin for the eradication of Helicobacter pylori in a high clarithromycin resistance area.
Helicobacter2013PMID 23714140
Twice-daily dosing of esomeprazole effectively inhibits acid secretion in CYP2C19 rapid metabolisers compared with twice-daily omeprazole, rabeprazole or lansoprazole.
Alimentary pharmacology & therapeutics2013PMID 24099474
Pharmacokinetics and relative bioavailability of a fixed-dose combination of enteric-coated naproxen and non-enteric-coated esomeprazole magnesium.
Journal of clinical pharmacology2012PMID 21628602Also measures esomeprazole
Effects of proton pump inhibitors on platelet function in patients receiving clopidogrel: a systematic review.
Drug safety2012PMID 22204719
A randomized, 2-period, crossover design study to assess the effects of dexlansoprazole, lansoprazole, esomeprazole, and omeprazole on the steady-state pharmacokinetics and pharmacodynamics of clopidogrel in healthy volunteers.
Journal of the American College of Cardiology2012PMID 22464259
Evaluation of the pharmacodynamics of acetylsalicylic acid 81 mg with or without esomeprazole 20 mg in healthy volunteers.
American journal of cardiovascular drugs2012PMID 22631032
Impact of acid suppression on upper gastrointestinal pH and motility.
Digestive diseases and sciences2011PMID 21086166Also returned by a PubMed search for esomeprazole
Esomeprazole with clopidogrel reduces peptic ulcer recurrence, compared with clopidogrel alone, in patients with atherosclerosis.
Gastroenterology2011PMID 21144850
Intragastric acidity during administration of generic omeprazole or esomeprazole - a randomised, two-way crossover study including CYP2C19 genotyping.
Alimentary pharmacology & therapeutics2011PMID 21175704
Evaluation of bioequivalence between a single-capsule formulation of esomeprazole 40 mg and acetylsalicylic acid 325 mg and the monotherapies given separately in healthy volunteers.
International journal of clinical pharmacology and therapeutics2011PMID 21255534
Long-term safety of naproxen and esomeprazole magnesium fixed-dose combination: phase III study in patients at risk for NSAID-associated gastric ulcers.
Current medical research and opinion2011PMID 21319944
Naproxen/esomeprazole fixed-dose combination: for the treatment of arthritic symptoms and to reduce the risk of gastric ulcers.
Drugs & aging2011PMID 21329403
Randomised clinical trial: twice daily esomeprazole 40 mg vs. pantoprazole 40 mg in Barrett's oesophagus for 1 year.
Alimentary pharmacology & therapeutics2011PMID 21385192
Prevention of peptic ulcers with esomeprazole in patients at risk of ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON).
Heart (British Cardiac Society)2011PMID 21415072